This demonstrates that the alternative splice events most strongly associated with QKI expression in breast cancers align closely with the QKI‐regulated events we had identified during EMT of cell lines, and more broadly provides strong evidence that QKI is a prominent driver of splicing changes in breast cancer. This evidence concerns the gene QKI and breast carcinoma.